PICALM (Q13492) variants and mutations
PICALM (also known as Q13492) is a human protein-coding gene encoding a phosphatidylinositol-binding clathrin assembly protein. It promotes clathrin-coated vesicle formation and membrane trafficking, including endocytosis and recycling of synaptic and hematopoietic proteins. Common variation near PICALM influences Alzheimer disease risk, while PICALM fusion genes can drive selected leukemias. This analysis covers 756 PICALM variants and mutations. Of these, 95% have computational variant effect predictions. Disease context includes Alzheimer disease, dementia, and acute myeloid leukemia. Example PICALM variants include S2Y, G3D, and T7A.
Variant analysis overview
- Gene: PICALM
- Protein: Q13492
- UniProt accession: Q13492
- Organism: Homo sapiens
- Variants analyzed: 756
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 609 unspecified-consequence records; 2 stop retained variant; 100 missense variants; 7 frameshift variants; 6 stop-gained variants; 3 splice-region variants; 2 stop lost; 29 synonymous variants; 1 protein altering variant; 1 substitution
- Prediction scores: 719 variants have prediction scores (95% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Alzheimer disease, dementia, acute myeloid leukemia, insomnia, systemic inflammatory response syndrome, Abnormality of the gastrointestinal tract, neurodegenerative disease, post term pregnancy, intestinal infectious disease, retinoschisis, retinal disorder, lacrimal apparatus disorder.
Protein structure and variant hotspots
- Protein features: 1 domains; 5 post-translational modification sites.
- Structural context: 96 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PICALM variants
Examples include S2Y, G3D, T7A, T7M, T7R, T11A, A12V, S16R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2Y (p.Ser2Tyr), TOPMed rs1458101059, REVEL 0.39, CADD 25.00
- G3D (p.Gly3Asp), Ensembl rs867182591, REVEL 0.52, CADD 26.80
- T7A (p.Thr7Ala), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, Variant assessed as somatic; moderate impact.
- T7M (p.Thr7Met), ExAC rs751824714, gnomAD rs751824714, REVEL 0.31, CADD 25.00
- T7R (p.Thr7Arg), ExAC rs751824714, gnomAD rs751824714, REVEL 0.34, CADD 25.30
- T11A (p.Thr11Ala), ExAC rs776273405, TOPMed rs776273405, gnomAD rs776273405, REVEL 0.18, CADD 18.50
- A12V (p.Ala12Val), Ensembl rs1565635210
- S16R (p.Ser16Arg), TOPMed rs997987522
- V17C (p.Val17Cys), NCI-TCGA TCGA novel, MetaLR 0.07, MetaSVM -1.14, Variant assessed as somatic; high impact.
- T18A (p.Thr18Ala), gnomAD rs2096483643, REVEL 0.21, CADD 21.80
- T18I (p.Thr18Ile), gnomAD rs1253473238, REVEL 0.31, CADD 24.30
- G19D (p.Gly19Asp), gnomAD rs1326185125, MetaLR 0.19, MetaSVM -0.68
- S20F (p.Ser20Phe), NCI-TCGA Cosmic COSV6267, cosmic curated COSV62670, MetaLR 0.12, MetaSVM -0.85, Variant assessed as somatic; moderate impact.
- A21V (p.Ala21Val), cosmic curated COSV10070, 1000Genomes rs187561271, REVEL 0.24, CADD 24.80
- V22I (p.Val22Ile), TOPMed rs1442635537, gnomAD rs1442635537, REVEL 0.14, CADD 19.30
- V22L (p.Val22Leu), TOPMed rs1442635537, gnomAD rs1442635537
- K24Q (p.Lys24Gln), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, MetaLR 0.17, MetaSVM -0.78, Variant assessed as somatic; moderate impact.
- T25A (p.Thr25Ala), rs771800238, ClinGen CA6216236, ClinVar RCV004099121, ExAC rs771800238, REVEL 0.14, CADD 17.10, Uncertain significance, not specified
- T25I (p.Thr25Ile), gnomAD rs1466084704, REVEL 0.23, CADD 28.70
- V26I (p.Val26Ile), TOPMed rs1053216507, REVEL 0.17, CADD 22.70
- T31A (p.Thr31Ala), NCI-TCGA TCGA novel, Uncertain significance, not specified
- H32D (p.His32Asp), ExAC rs773948451, gnomAD rs773948451, REVEL 0.35, CADD 24.90
- I34M (p.Ile34Met), 1000Genomes rs146840505, ESP rs146840505, ExAC rs146840505, TOPMed rs146840505, REVEL 0.07, CADD 22.00
- I34T (p.Ile34Thr), gnomAD rs2096483204, REVEL 0.13, CADD 24.80
- I34V (p.Ile34Val), 1000Genomes rs558010093, ExAC rs558010093, gnomAD rs558010093, REVEL 0.04, CADD 19.20
- M35L (p.Met35Leu), Ensembl rs2096483129
- M35T (p.Met35Thr), cosmic curated COSV62673, ExAC rs201030001, gnomAD rs201030001
- M35V (p.Met35Val), NCI-TCGA TCGA novel, MetaLR 0.11, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- G36E (p.Gly36Glu), Ensembl rs1482131849
- G36R (p.Gly36Arg), NCI-TCGA TCGA novel, ExAC rs756151627, Variant assessed as somatic; moderate impact.
- K38N (p.Lys38Asn), ExAC rs781418654, gnomAD rs781418654, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, REVEL 0.27, CADD 29.20, Variant assessed as somatic; moderate impact.
- K38R (p.Lys38Arg), NCI-TCGA Cosmic COSV6267, cosmic curated COSV62670, MetaLR 0.18, MetaSVM -0.60, Variant assessed as somatic; moderate impact.
- K39R (p.Lys39Arg), ExAC rs757415973, gnomAD rs757415973, REVEL 0.16, CADD 25.30
- L42V (p.Leu42Val), ExAC rs759002840, TOPMed rs759002840, gnomAD rs759002840, REVEL 0.18, CADD 23.80
- D43N (p.Asp43Asn), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.07, Variant assessed as somatic; moderate impact.
- Y44D (p.Tyr44Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y44N (p.Tyr44Asn), gnomAD rs1203356239, REVEL 0.33, CADD 28.50
- Y44S (p.Tyr44Ser), Ensembl rs2095752983, REVEL 0.34, CADD 27.70
- I46V (p.Ile46Val), ExAC rs763758108, gnomAD rs763758108, MetaLR 0.20, MetaSVM -0.80
- C48Y (p.Cys48Tyr), ExAC rs762683708, gnomAD rs762683708, REVEL 0.37, CADD 24.00
- T49S (p.Thr49Ser), Ensembl rs2095752875, MetaLR 0.28, MetaSVM -0.38
- N50H (p.Asn50His), ExAC rs775211588, gnomAD rs775211588, REVEL 0.35, CADD 26.40
- M52I (p.Met52Ile), NCI-TCGA Cosmic COSV6266, cosmic curated COSV62669, Variant assessed as somatic; moderate impact.
- M52V (p.Met52Val), ExAC rs769730320, TOPMed rs769730320, gnomAD rs769730320, MetaLR 0.09, MetaSVM -1.08
- N53T (p.Asn53Thr), Ensembl rs1565481046, REVEL 0.38, CADD 26.70, Uncertain significance, not specified
- N55S (p.Asn55Ser), ESP rs141093733, ExAC rs141093733, TOPMed rs141093733, gnomAD rs141093733, REVEL 0.23, CADD 19.60
- N55Y (p.Asn55Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I56M (p.Ile56Met), Ensembl rs1168067430, MetaLR 0.10, MetaSVM -1.02
- P57L (p.Pro57Leu), TOPMed rs2095752639, gnomAD rs2095752639, REVEL 0.58, CADD 28.20
- Q58H (p.Gln58His), gnomAD rs1257241720
- L59M (p.Leu59Met), gnomAD rs1012378518, REVEL 0.23, CADD 22.50
- S62C (p.Ser62Cys), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, Variant assessed as somatic; moderate impact.
- R66I (p.Arg66Ile), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, MetaLR 0.37, MetaSVM -0.14, Variant assessed as somatic; moderate impact.
- T68A (p.Thr68Ala), ExAC rs772279792, gnomAD rs772279792, REVEL 0.22, CADD 19.20
- T68N (p.Thr68Asn), ExAC rs748465366, gnomAD rs748465366, REVEL 0.10, CADD 22.70
- T68S (p.Thr68Ser), ExAC rs772279792, gnomAD rs772279792, REVEL 0.08, CADD 20.50
- N69D (p.Asn69Asp), Ensembl rs1565480624, REVEL 0.25, CADD 24.30
- N69S (p.Asn69Ser), TOPMed rs1355269529, REVEL 0.13, CADD 22.30
- S71T (p.Ser71Thr), Ensembl rs2095752150, MetaLR 0.16, MetaSVM -1.00
- W72* (p.Trp72Ter), gnomAD rs1356400915
- W72C (p.Trp72Cys), cosmic curated COSV99074, Ensembl rs1593129874, MetaLR 0.32, MetaSVM -0.19
- F76L (p.Phe76Leu), ExAC rs755598180, gnomAD rs755598180, REVEL 0.24, CADD 23.90
- S78P (p.Ser78Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S78Y (p.Ser78Tyr), gnomAD rs2095751876, REVEL 0.47, CADD 28.30
- L79V (p.Leu79Val), rs1468771678, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, Ensembl rs1468771678, REVEL 0.63, CADD 26.00, Variant assessed as somatic; moderate impact.
- I80T (p.Ile80Thr), TOPMed rs1431764950, gnomAD rs1431764950, REVEL 0.48, CADD 26.40
- I80V (p.Ile80Val), rs754371476, ClinGen CA6216181, ClinVar RCV004503511, ExAC rs754371476, REVEL 0.08, CADD 21.00, Uncertain significance, not specified
- T82A (p.Thr82Ala), rs780886080, ClinGen CA6216180, ClinVar RCV004503512, ExAC rs780886080, REVEL 0.27, CADD 26.40, Uncertain significance, not specified
- H83R (p.His83Arg), gnomAD rs1316349561, REVEL 0.82, CADD 26.30
- H84Q (p.His84Gln), ESP rs371017558, ExAC rs371017558, gnomAD rs371017558, REVEL 0.34, CADD 25.00
- H84Y (p.His84Tyr), TOPMed rs948382845, gnomAD rs948382845, REVEL 0.62, CADD 28.00, Uncertain significance, not specified
- V87L (p.Val87Leu), Ensembl rs2136771689
- V87M (p.Val87Met), Ensembl rs2136771689, REVEL 0.23, CADD 23.20
- N90S (p.Asn90Ser), gnomAD rs1474509894, REVEL 0.32, CADD 25.90
- R92H (p.Arg92His), gnomAD rs1167033869, REVEL 0.65, CADD 33.00
- R92L (p.Arg92Leu), gnomAD rs1167033869, REVEL 0.64, CADD 33.00
- I94T (p.Ile94Thr), TOPMed rs1426848837, gnomAD rs1426848837, REVEL 0.30, CADD 24.70
- T102A (p.Thr102Ala), ExAC rs779466539, gnomAD rs779466539, REVEL 0.36, CADD 23.40
- L106S (p.Leu106Ser), Ensembl rs750147583
- S107R (p.Ser107Arg), NCI-TCGA TCGA novel, REVEL 0.35, CADD 23.40, Variant assessed as somatic; moderate impact.
- F109S (p.Phe109Ser), ExAC rs780443419, gnomAD rs780443419, REVEL 0.70, CADD 29.50
- L110F (p.Leu110Phe), NCI-TCGA TCGA novel, REVEL 0.20, CADD 31.00, Variant assessed as somatic; high impact.
- D111G (p.Asp111Gly), TOPMed rs1296358447, REVEL 0.75, CADD 33.00
- K112E (p.Lys112Glu), gnomAD rs1276734217, REVEL 0.47, CADD 25.10
- K112R (p.Lys112Arg), NCI-TCGA Cosmic COSV6266, cosmic curated COSV62669, REVEL 0.19, CADD 24.60, Variant assessed as somatic; moderate impact.
- D119N (p.Asp119Asn), TOPMed rs2095580867, REVEL 0.27, CADD 23.50
- M120K (p.Met120Lys), NCI-TCGA Cosmic COSV6267, cosmic curated COSV62671, MetaLR 0.19, MetaSVM -0.81, Variant assessed as somatic; moderate impact.
- T122A (p.Thr122Ala), rs1464994938, NCI-TCGA Cosmic COSV6267, cosmic curated COSV62673, gnomAD rs1464994938, REVEL 0.52, CADD 24.20, Variant assessed as somatic; moderate impact.
- R125S (p.Arg125Ser), Ensembl rs200363412, REVEL 0.46, CADD 24.40
- R126Q (p.Arg126Gln), rs967543022, NCI-TCGA Cosmic COSV6267, cosmic curated COSV62673, Ensembl rs967543022, REVEL 0.46, CADD 32.00, Variant assessed as somatic; moderate impact.
- R126W (p.Arg126Trp), rs1160579539, NCI-TCGA Cosmic COSV6266, cosmic curated COSV62668, gnomAD rs1160579539, REVEL 0.60, CADD 30.00, Variant assessed as somatic; moderate impact.
- Y127F (p.Tyr127Phe), Ensembl rs2136514607, MetaLR 0.57, MetaSVM 0.22
- S128G (p.Ser128Gly), TOPMed rs2095580388, REVEL 0.36, CADD 24.60
- R129G (p.Arg129Gly), ExAC rs747618387, gnomAD rs747618387, SIFT 0.26
- Y130* (p.Tyr130Ter), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, Variant assessed as somatic; high impact.
- N132H (p.Asn132His), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, Variant assessed as somatic; moderate impact.
- A135T (p.Ala135Thr), gnomAD rs2095580084, REVEL 0.56, CADD 27.20
- V136A (p.Val136Ala), NCI-TCGA Cosmic COSV6267, cosmic curated COSV62670, REVEL 0.24, CADD 23.00, Variant assessed as somatic; moderate impact.
- V136I (p.Val136Ile), NCI-TCGA TCGA novel, REVEL 0.10, CADD 22.90, Variant assessed as somatic; moderate impact.
- S137A (p.Ser137Ala), 1000Genomes rs531548903, ExAC rs531548903, TOPMed rs531548903, gnomAD rs531548903, REVEL 0.32, CADD 23.10
- R139K (p.Arg139Lys), ExAC rs754558342, gnomAD rs754558342, REVEL 0.45, CADD 26.80
- Q140* (p.Gln140Ter), Ensembl rs1014468074
- D144N (p.Asp144Asn), ESP rs145115354, ExAC rs145115354, gnomAD rs145115354, MetaLR 0.18, MetaSVM -0.79
- K147E (p.Lys147Glu), ExAC rs756054547, gnomAD rs756054547, REVEL 0.33, CADD 27.80
- K147N (p.Lys147Asn), Ensembl rs2095579539, MetaLR 0.18, MetaSVM -0.87
- V148M (p.Val148Met), Ensembl rs2095579500, REVEL 0.10, CADD 21.90
- K149R (p.Lys149Arg), TOPMed rs1297090510, REVEL 0.25, CADD 24.90
- R150G (p.Arg150Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G151A (p.Gly151Ala), ExAC rs762002253, gnomAD rs762002253, REVEL 0.34, CADD 33.00
- G151W (p.Gly151Trp), NCI-TCGA TCGA novel, REVEL 0.62, CADD 33.00, Variant assessed as somatic; moderate impact.
- A152G (p.Ala152Gly), ESP rs377463080, ExAC rs377463080, gnomAD rs377463080, REVEL 0.07, CADD 23.20
- G154R (p.Gly154Arg), TOPMed rs2095456616, SIFT 0.00
- V155A (p.Val155Ala), NCI-TCGA Cosmic COSV6267, cosmic curated COSV62670, REVEL 0.44, CADD 26.70, Variant assessed as somatic; moderate impact.
- V155D (p.Val155Asp), Ensembl rs1565417765, MetaLR 0.17, MetaSVM -0.90
- M156V (p.Met156Val), TOPMed rs1487115040, REVEL 0.44, CADD 23.60
- R157I (p.Arg157Ile), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, REVEL 0.55, CADD 28.90, Variant assessed as somatic; moderate impact.
- T158A (p.Thr158Ala), Ensembl rs12800974, REVEL 0.42, CADD 24.20
- T158P (p.Thr158Pro), rs12800974, UniProt VAR 028191, Ensembl rs12800974
- M159I (p.Met159Ile), TOPMed rs2095456273, REVEL 0.52, CADD 23.80
- M159R (p.Met159Arg), gnomAD rs746285694, REVEL 0.72, CADD 26.80
- M159T (p.Met159Thr), gnomAD rs746285694, REVEL 0.70, CADD 23.80
- M159V (p.Met159Val), 1000Genomes rs373046489, ESP rs373046489, ExAC rs373046489, TOPMed rs373046489, REVEL 0.39, CADD 23.30
- T161P (p.Thr161Pro), gnomAD rs1374565778, REVEL 0.29, CADD 24.40
- V168G (p.Val168Gly), TOPMed rs2095455998, gnomAD rs2095455998, REVEL 0.35, CADD 28.30
- V168I (p.Val168Ile), ExAC rs757198200, TOPMed rs757198200, gnomAD rs757198200, REVEL 0.03, CADD 21.60, Uncertain significance
- V168L (p.Val168Leu), ExAC rs757198200, TOPMed rs757198200, gnomAD rs757198200, REVEL 0.07, CADD 16.70, Uncertain significance, not specified
- P169R (p.Pro169Arg), Ensembl rs2095455902, REVEL 0.54, CADD 28.20
- P169S (p.Pro169Ser), gnomAD rs956054833, REVEL 0.35, CADD 24.20
- P169P (p.Pro169Pro), gnomAD 11-85960718-G-T, CADD 14.50
- p.Pro205delinsLeuSerSer, gnomAD 11-85960719-G-GAG, CADD 20.90
- P169H (p.Pro169His), gnomAD 11-85960719-G-T, CADD 21.70
- P169T (p.Pro169Thr), rs1476235681, gnomAD 11-85960720-G-T, CADD 22.10
- P169A (p.Pro169Ala), rs1207300379, gnomAD 11-85960744-G-C, CADD 22.20
- I170V (p.Ile170Val), gnomAD rs1470245732, REVEL 0.15, CADD 21.20
- I171V (p.Ile171Val), ExAC rs751759837, gnomAD rs751759837, REVEL 0.13, CADD 22.40
- Q172R (p.Gln172Arg), ExAC rs764258400, gnomAD rs764258400, REVEL 0.78, CADD 27.00
- N173K (p.Asn173Lys), NCI-TCGA TCGA novel, REVEL 0.14, CADD 22.20, Variant assessed as somatic; moderate impact.
- Q174H (p.Gln174His), 1000Genomes rs592297, ESP rs592297, ExAC rs592297, TOPMed rs592297, REVEL 0.56, CADD 23.00, Benign
- M175V (p.Met175Val), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, REVEL 0.27, CADD 22.70, Variant assessed as somatic; moderate impact.
- A177T (p.Ala177Thr), gnomAD rs1253380893, REVEL 0.37, CADD 24.40
- A177V (p.Ala177Val), Ensembl rs2095455631, REVEL 0.45, CADD 23.30
- L178F (p.Leu178Phe), 1000Genomes rs567632388, ExAC rs567632388, gnomAD rs567632388, REVEL 0.68, CADD 29.80, Uncertain significance, not specified
- L178H (p.Leu178His), NCI-TCGA Cosmic COSV6266, NCI-TCGA Cosmic COSV6267, cosmic curated COSV62672, Variant assessed as somatic; moderate impact.
- L178R (p.Leu178Arg), NCI-TCGA Cosmic COSV6266, cosmic curated COSV62669, NCI-TCGA Cosmic COSV6267, Variant assessed as somatic; moderate impact.
- L179P (p.Leu179Pro), ExAC rs765338634, gnomAD rs765338634, REVEL 0.70, CADD 31.00
- F181V (p.Phe181Val), NCI-TCGA TCGA novel, MetaLR 0.19, MetaSVM -0.76, Variant assessed as somatic; moderate impact.
- V183I (p.Val183Ile), rs1273658262, ClinGen CA381990358, cosmic curated COSV62674, ClinVar RCV004503513, REVEL 0.07, CADD 24.40, Uncertain significance, not specified
- N184D (p.Asn184Asp), TOPMed rs1239694127, gnomAD rs1239694127, REVEL 0.17, CADD 26.50
- N184H (p.Asn184His), TOPMed rs1239694127, gnomAD rs1239694127, REVEL 0.20, CADD 23.70
- S185N (p.Ser185Asn), rs1172716942, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10070, gnomAD rs1172716942, REVEL 0.05, CADD 23.20, Variant assessed as somatic; moderate impact.
- S185C (p.Ser185Cys), gnomAD 11-85960704-G-C, CADD 22.00
- S185P (p.Ser185Pro), rs1375070331, gnomAD 11-85960705-A-G, CADD 22.20
- S185S (p.Ser185Ser), gnomAD 11-85960730-T-G, CADD 22.00
- S185G (p.Ser185Gly), gnomAD 11-85960747-T-C, CADD 22.30
- S185R (p.Ser185Arg), gnomAD 11-85960747-T-G, CADD 22.30
- S185I (p.Ser185Ile), gnomAD 11-85960752-C-A, CADD 21.20
- S185Y (p.Ser185Tyr), gnomAD 11-85960755-G-T, CADD 21.90
- S185T (p.Ser185Thr), rs2093660988, gnomAD 11-85960760-GC-G, CADD 20.50
- S185F (p.Ser185Phe), gnomAD 11-85960764-G-A, CADD 22.00
- S185L (p.Ser185Leu), rs770007400, gnomAD 11-85960773-G-A, CADD 22.40
- S185* (p.Ser185Ter), gnomAD 11-85960773-G-T, CADD 22.70
- S185A (p.Ser185Ala), gnomAD 11-85960774-A-C, CADD 21.80
- N186K (p.Asn186Lys), ExAC rs745676394, gnomAD rs745676394, REVEL 0.19, CADD 22.00
- N186S (p.Asn186Ser), 1000Genomes rs144544770, ESP rs144544770, ExAC rs144544770, TOPMed rs144544770, REVEL 0.24, CADD 23.60
- E187* (p.Glu187Ter), NCI-TCGA Cosmic COSV6266, cosmic curated COSV62669, CADD 42.00, Variant assessed as somatic; high impact.
- E187D (p.Glu187Asp), TOPMed rs1300270545, gnomAD rs1300270545, REVEL 0.12, CADD 22.40
- L188I (p.Leu188Ile), Ensembl rs74727972, REVEL 0.23, CADD 27.00
- L188L (p.Leu188Leu), rs1398922666, gnomAD 11-85960775-C-T, CADD 20.70
- L188P (p.Leu188Pro), gnomAD 11-85960776-A-G, CADD 22.60
- L188M (p.Leu188Met), gnomAD 11-85960777-G-T, CADD 22.20
- L188V (p.Leu188Val), gnomAD 11-85960777-G-C, CADD 22.30
- N190S (p.Asn190Ser), gnomAD rs1409030565, REVEL 0.39, CADD 25.80
- G191E (p.Gly191Glu), NCI-TCGA TCGA novel, REVEL 0.53, CADD 27.70, Variant assessed as somatic; moderate impact.
- G191R (p.Gly191Arg), gnomAD rs202022146, REVEL 0.57, CADD 26.80
- G191W (p.Gly191Trp), gnomAD rs202022146
- G191G (p.Gly191Gly), gnomAD 11-85960727-T-C, CADD 22.50
- V192I (p.Val192Ile), ExAC rs781133632, gnomAD rs781133632, REVEL 0.14, CADD 23.40
- I193V (p.Ile193Val), TOPMed rs2095413215, MetaLR 0.18, MetaSVM -0.81
- A195V (p.Ala195Val), rs778042984, ExAC rs778042984, gnomAD rs778042984, REVEL 0.28, CADD 32.00, Variant assessed as somatic; moderate impact.
- A195A (p.Ala195Ala), rs2093661212, gnomAD 11-85960766-T-C, CADD 16.90
Public PICALM analysis runs
- PICALM analysis run — PICALM (756 variants) — completed 2026-08-21